WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the second quarter ended June 30, 2024. "We continue to work closely with the Nufarm team to finalize the asset purchase agreement announced in July,” said Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10. “We... Read More

Nufarm to pay up to USD $5 million in consideration for the license The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (“MOU”) and License... Read More

WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that U.K.-based Rothamsted Research Limited (“Rothamsted”) has granted to the Company an exclusive global, commercial license to advanced technology for producing sustainable omega-3 products in Camelina sativa (“Camelina”).... Read More

EPA approved an amendment to the label of INTERLINE herbicide to include Camelina The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that UPL Ltd. (“UPL”) has received U.S. Environmental Protection Agency (“EPA”)... Read More

WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the first quarter ended March 31, 2024. "In the first quarter of 2024, we made the strategic decision to focus our resources on the commercialization of Camelina products targeting the aquafeed and nutritional markets for omega-3 fatty... Read More

WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that Company has received a final delisting notice from Nasdaq. The delisting is a result of failure to regain compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule... Read More

WOBURN, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that it will effect a 1-for-24 reverse stock split of its common stock, following stockholder approval of the reverse stock split at its special stockholder meeting held on April 26, 2024. The 1-for-24 reverse stock split will be effective as of 5:00 p.m.... Read More

Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market Advanced regulatory and seed scale-up program for omega-3 Camelina E3902 oil trait in Camelina cleared by regulatory authority for planting in Canada Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update WOBURN, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Yield10... Read More

WOBURN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2023 financial results and provide a corporate update on Monday, April 1, 2024. Management will host a conference call on Monday, April 1, 2024.at 4:30 p.m. ET to review financial results, share... Read More

WOBURN, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today reported that the Plant Biosafety Office (“PBO”) of the Canadian Food Inspection Agency (“CFIA”) recently reviewed information on the Company’s E3902 Camelina sativa (“Camelina”) and determined that E3902 is not a Plant with Novel Trait (PNT) and is not subject to a... Read More

Yield10 achieves significant milestone enabling ramp-up to commercial scale production of omega-3 fatty acids in Camelina Omega-3 Camelina potentially represents a novel solution to the market need for omega-3 oils used in aquafeed for farmed fish and in human nutrition WOBURN, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,... Read More

WOBURN, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today reported that its proprietary varieties of winter Camelina sativa (“Camelina”) in development responded as expected to herbicides in the first field tests conducted in the United States. Yield10 tested winter Camelina engineered with tolerance to glufosinate (“HT”),... Read More

WOBURN, Mass. and LONGMONT, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, and VISION Bioenergy Oilseeds , LLC (“VISION”), a U.S. agricultural company focused on commercial production of ultra-low carbon biofuel feedstock, today... Read More

Prioritizes Activities to Advance Omega-3 Camelina Program in 2024 Reports Completion of Contra Season Production of Omega-3 Camelina Seed in Chile Company also Provides Update on Nasdaq Status WOBURN, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today provided an update on its Omega-3 Camelina program. The Company has taken... Read More

WOBURN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company recently filed a request for a Regulatory Status Review (“RSR”) with USDA-APHIS Biotechnology Regulatory Services (“BRS”) under the Sustainable, Ecological, Consistent, Uniform, Responsible, Efficient (“SECURE”) Rule for proprietary elite... Read More

Yield10 Achieves a Significant Milestone in the Development of Camelina as a Commercial Crop for Producing Biofuels and Omega-3 Oils On Track for Commercial Launch of Glufosinate Tolerant Camelina as early as 2025 WOBURN, Mass., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that USDA-APHIS’s Biotechnology Regulatory... Read More

Establishes "Camelina Seed Genetics to Biofuel" Platform Advances Herbicide Tolerant Camelina Varieties toward Commercialization Exercises Option to Finalize Exclusive, Global Commercial License to Advanced Omega-3 Technology Management will host a conference call today at 4:30 pm (ET) WOBURN, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural... Read More

WOBURN, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its third quarter 2023 financial results and provide a corporate update on Tuesday, November 14, 2023. Management will host a conference call on Tuesday, November 14, 2023 at 4:30 p.m. ET to review financial results, share... Read More

Yield10 Bioscience and BioMar Group have signed an LOI to form a long-term partnership to commercialize a Camelina crop containing enriched levels of EPA and DHA equal to fish oil. After a decade of research, this Omega-3 Camelina technology is now advancing toward market availability and has the potential to become another important, high-quality supplement to the scarce supply of marine long-chain fatty acids. WOBURN,... Read More

WOBURN, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has exercised its option to finalize an exclusive global, commercial license to advanced omega-3 production technology from U.K.-based Rothamsted Research Limited (“Rothamsted”). In 2020, Yield10 signed an exclusive collaboration agreement... Read More

On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025 First field tests of stacked herbicide tolerant winter Camelina underway Recent positive field tests demonstrate stacked herbicide traits in spring Camelina Herbicide tolerance in Camelina supports large acreage production of low-carbon intensity feedstock oil for the biofuel market WOBURN, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) --... Read More

WOBURN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the harvest of a majority of the winter and spring Camelina sativa ("Camelina”) grain produced under grower contracts in 2022/2023 has been completed. This harvest marks the establishment of the Company’s “Camelina Seed Genetics to Biofuel” platform, as... Read More

WOBURN, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that management will participate in the H.C. Wainwright 25 th Annual Global Investment Conference being held on September 11-13, 2023, at the Lotte New York Palace Hotel. President and Chief Executive Officer Oliver Peoples, Ph.D. will present a corporate... Read More

WOBURN, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the closing of its previously announced public offering of 5,750,000 units at a public offering price of $0.65 per unit. Each unit consisted of one share of common stock and one warrant to purchase one share of common stock. The warrants are immediately... Read More

Harvesting underway for contracted winter and spring Camelina acres for the biofuels market Reported positive results in first field tests of stacked herbicide tolerant Camelina Filed a request for regulatory status review with USDA-APHIS for omega-3 (EPA) Camelina Strengthened balance sheet with recent financing Management will host a conference call today at 4:30 pm (ET) WOBURN, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) --... Read More

WOBURN, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its second quarter 2023 financial results and provide a corporate update on Monday, August 14, 2023. Management will host a conference call on Monday, August 14, 2023 at 4:30 p.m. ET to review financial results, share corporate... Read More

WOBURN, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the pricing of its public offering of 5,750,000 units at a public offering price of $0.65 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. The warrants will be immediately exercisable at an... Read More

WOBURN, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced positive results in the first field test of stacked herbicide tolerance (“HT”) traits in Camelina. These proprietary stacked HT Camelina varieties developed by Yield10 demonstrate tolerance to the application of an over-the-top herbicide for weed control as... Read More

Omega-3 (EPA) Camelina planted at acre-scale in US nearing maturity Development program moving forward at a solid pace toward commercialization WOBURN, Mass., July 26, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the... Read More

Executing commercial strategy for elite Camelina in the biofuels market Met target for 2023 contracted spring Camelina acres Permitting complete, planting underway for spring seed scale-up and field testing program Management will host a conference call today at 4:30 pm (ET) to review financial results and provide a corporate update WOBURN, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN)... Read More

WOBURN, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its first quarter 2023 financial results and provide a corporate update on Wednesday, May 10, 2023. Management will host a conference call on Wednesday, May 10, 2023 at 4:30 p.m. ET to review financial results, share corporate... Read More

WOBURN, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that it has agreed to sell $3.0 million of its shares of common stock (or prefunded warrants in lieu thereof) in a registered direct offering and warrants in a concurrent private placement with investors including a certain institutional investor and an... Read More

WOBURN, Mass., May 01, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that it has signed a non-binding Letter of Intent (“LOI”) with Marathon Petroleum Corp. (NYSE: MPC, “Marathon”) for a potential investment and offtake agreement for low-carbon intensity Camelina feedstock oil for use in renewable fuels production. Marathon is... Read More

Executing strategy to build supply chain alliances for the production of low-carbon intensity Camelina feedstock oil for the biofuels market Advancing development of herbicide tolerant Camelina varietiesAccelerating development of omega-3 Camelina Management will host a conference call today at 4:30 p.m. (ET) to reviewfinancial results and provide a corporate update WOBURN, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- Yield10... Read More

WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2022 financial results and provide a corporate update on Tuesday, March 14, 2023. Management will host a conference call on Tuesday, March 14, 2023 at 4:30 p.m. ET to review financial results,... Read More

WOBURN, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that it signed a Memorandum of Understanding (“MOU”) with American Airlines, Inc. (NASDAQ: AAL) on February 27, 2023 to collaborate in developing the value chain for Camelina as a low-carbon feedstock oil for sustainable aviation fuel (“SAF”). American is... Read More

Second field trial confirms Camelina tolerance to over-the-top herbicide application Greenhouse studies support proof-of-concept for stacked herbicide traits in Camelina Yield10 filed RSR under USDA-APHIS’s SECURE Rule for herbicide tolerant Camelina WOBURN, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc . (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced key... Read More

WOBURN, MA / ACCESSWIRE / February 16, 2023 / Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, has been invited to present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference, which is being held virtually on February 21 st through February 24 th , 2023. Yield10 CEO Oliver Peoples, Ph.D. is scheduled to present on Tuesday, February 21, 2023 at... Read More

WOBURN, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that it has signed with Mitsubishi Corporation (“Mitsubishi”) a Memorandum of Understanding (“MOU”) to evaluate the establishment of a partnership to supply, offtake and market Camelina as a low-carbon feedstock oil for biofuels. Mitsubishi Corporation... Read More

WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the Canaccord Genuity AgriFood Tech Innovation Virtual Forum on December 1, 2022 at 1:30pm ET. A live webcast of the presentation and a replay will be available on the... Read More

Grower contracts in place for winter 2022/2023 Development of herbicide tolerance traits in Camelina on track Collaboration with Rothamsted Research for omega-3 technology extended through 2023 Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update WOBURN, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc . (Nasdaq:YTEN) ("Yield10" or the... Read More

Advancing development of herbicide tolerant Camelina Building commercial seed inventory available to growers in 2023 and beyond WOBURN, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc . (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has begun its winter 2022/2023 field test and seed production program for Camelina at sites in the United... Read More

Yield10 Bioscience, Inc . (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its third quarter 2022 financial results and provide a corporate update on Monday, November 14, 2022. Management will host a conference call on Monday, November 14, 2022 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business... Read More

Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, has been invited to present at the MicroCap Rodeo presents: The Windy City Roundup 2022 investor conference, which is being held in-person on October 12 th - 13 th , 2022. Yield10 is scheduled to present on Wednesday, October 12, 2022 at 3:30 pm CDT (4:30 pm EDT). Management will be available for one-on-one meetings to be... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that Willie Loh, Ph.D., was named to the Company’s Board of Directors effective October 4, 2022. Dr. Loh previously served as a Special Commercial and Technical Advisor to the Company. Dr. Loh was formerly Vice President, Market Development of Cargill Inc.’s Global Edible Oils Solutions group in North... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the International Symposium on Biopolymers (“ISBP”) 2022 Conference. The event is taking place September 12 through September 16, 2022 in Sion, Switzerland. Dr. Snell will make a presentation on Friday, September 16, during the session... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the 24 th Annual H.C. Wainwright Global Investment Conference on September 13, 2022 at 2:00 pm ET. The conference is being held on September 12 – 14, 2022 at the Lotte New York Palace Hotel. A live webcast of the... Read More

Winter program targeting more than 1,000 acres through grower contracts On track to achieve key 2022 goal of identifying herbicide tolerant Camelina lines for seed scale up and commercial development Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company,... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its second quarter 2022 financial results and provide a corporate update on Wednesday, August 10, 2022. Management will host a conference call on Wednesday, August 10, 2022 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10 Bioscience” or the “Company”), an agricultural bioscience company, today announced the name change of its wholly-owned Canadian subsidiary to Yield10 Oilseeds Inc. from Metabolix Oilseeds, Inc. effective July 12, 2022. This name change creates an alignment of Yield10 Bioscience’s Canadian subsidiary with the branding associated with the Yield10 Bioscience business, which is... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the CROPS 2022: Improving Agriculture Through Genomics Conference taking place June 13 through June 16, 2022 in Huntsville, Alabama. Dr. Snell will make a presentation on Wednesday, June 15, during the session entitled “Plant Engineering... Read More

Yield10 Bioscience, Inc . (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the H.C. Wainwright Global Hybrid Investment Conference. The conference is being held on May 23 – 26, 2022 at the Fontainebleau Hotel in Miami Beach, FL. Event: H.C. Wainwright Global Hybrid Investment Conference Time:... Read More

-Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the three months ended March 31, 2022. “The development of Camelina as a commercial oilseed crop addresses three fundamental challenges facing not just our... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its first quarter 2022 financial results and provide a corporate update on Wednesday, May 11, 2022. Management will host a conference call on Wednesday, May 11, 2022 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update.... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today named Willie Loh, Ph.D., as a special advisor to the Board of Directors and Management of the Company, effective immediately. Dr. Loh previously served as Vice President, Market Development, Global Edible Oils Division at Cargill Incorporated, the global food and agriculture company. “We are excited to have Willie... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will participate at the Maxim Group 2022 Virtual Growth Conference, which is being held March 28-30, 2022. Dr. Peoples will present a corporate overview which will become available as of 9:00 am ET on Monday, March 28, 2022. The presentation can be viewed here.... Read More

Establishing the Camelina crop as a replenishable reserve of feedstock oil for biofuels Winter Camelina could expand acres available for feedstock oil while improving soil health and providing sustainability benefits Yield10 publishes white paper entitled “Biofuels and Bioplastics Commercial Development Plan” Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today... Read More

Near-term commercial focus on the Renewable Diesel market Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the three and twelve months ended December 31, 2021. "In 2021 we executed against our strategic plan to... Read More

Acre-scale seed production planned in spring 2022 First winter PHA Camelina planting expected in fall 2022 Research program to produce PHA co-polymers is underway Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced recent advances in the development of Camelina as a platform for the production of PHA bioplastic directly in the seed. Field work completed... Read More

Company is Scaling up Camelina Line E3902 Seed Production and Developing Herbicide Tolerant Lines Renewable Diesel for Transportation is Driving Demand for Vegetable Oil in the U.S. and Canada Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced an update on its Camelina line E3902 development program for the purpose of producing low-carbon feedstock oil for... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2021 financial results and provide a corporate update on Wednesday, March 9, 2022. Management will host a conference call on Wednesday, March 9, 2022 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that 2021 field test results show that the trait C3020 tested in Camelina and C3007 tested in canola produce increases in seed oil content. Further field testing of these novel oil content traits is planned in spring 2022. Summary of 2021 Field Test results for C3020 and C3007 C3020: Yield10 tested C3020... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced the hiring of Darren Greenfield to serve as the Company’s Senior Director of Seed Operations. In this newly created position, Mr. Greenfield will be responsible for Camelina seed scale up and commercial contract production. He brings over 25 years of experience with major agriculture companies managing the development and commercial... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a corporate presentation at the H.C. Wainwright Bioconnect Investment Conference, which is being held virtually from January 10 – 13, 2022. Yield10 management will also be available to participate in one-on-one meetings with investors who are registered to attend the conference.... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that management will participate at the Benzinga Global Small Cap Conference on December 9, 2021. President and Chief Executive Officer Oliver Peoples, Ph.D. will deliver his presentation at 10:30 AM EST on Thursday, December 9, 2021. Dr. Peoples will also be available to participate in one-on-one meetings with investors who are... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the Canola Week 2021 Conference taking place in virtual format November 30 through December 2, 2021. Dr. Snell will make a pre-recorded virtual presentation on December 2, 2021 as part of Canola Innovation Day during the session “Cutting Edge Molecular... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial and operational results for the three and nine months ended September 30, 2021. “During the third quarter we continued to execute against our strategic objectives for 2021," said Oliver Peoples, Ph.D., Chief Executive Officer of Yield10 Bioscience. "We completed the harvest of Camelina in our 2021 spring field tests and seed... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its third quarter 2021 financial results and provide a corporate update on Wednesday, November 10, 2021. Management will host a conference call on Wednesday, November 10, 2021 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will present at the Maxim Group Global AgTech Conference, which is being held virtually on October 14, 2021. The event will consist of four virtual panels with participation by executive management from multiple companies in the AgTech sector. Dr. Peoples will be presenting on the... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a corporate presentation at the H.C. Wainwright 23 rd Annual Global Investment Conference, which is being held virtually from September 13 – 15, 2021. Yield10 management will also be available to participate in one-on-one meetings with investors who are registered to attend the... Read More

Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review Financial Results and Provide a Corporate Update Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and six months ended June 30, 2021. "We are focused on executing against our core business strategy of utilizing Camelina as a platform crop to produce food, fuel, and PHA... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its second quarter 2021 financial results and provide a corporate update on Wednesday, August 11, 2021. Management will host a conference call on Wednesday, August 11, 2021 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has completed planting of its 2021 Field Test and Seed Scale Up program at all contracted sites in the United States, Canada, and Argentina. Yield10’s 2021 Field Test program is designed to test several varieties of elite Camelina, as well as seed yield and oil content traits. In addition, Yield10 has contracted with a seed... Read More

Dr. Munyikwa Appointed as Director of Regulatory Affairs Dr. Renegar Appointed as Director, Business Analytics and Operations Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced two new hires. Tichafa Munyikwa, Ph.D. has been appointed Director of Regulatory Affairs. In this new role, Dr. Munyikwa will be responsible for developing and executing regulatory strategy for Yield10’s... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the 2021 Synthetic Biology: Engineering, Evolution & Design (SEED) conference, taking place in a virtual format June 15 through June 18, 2021. Dr. Snell will present at the conference on Wednesday, June 16 at 10:55 am PDT (1:55 pm EDT) during Session 4: Synthetic... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will give a corporate presentation at the LD Micro Virtual Invitational XI investor conference on Wednesday, June 9, 2021 at 3:30 pm ET, Track Two. The virtual conference and presentation will be held via webcast from June 8 to 10, 2021. Register to watch... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three months ended March 31, 2021. "We remain solidly on track for progressing our technical and business plans to support a specialty products business based on our Camelina platform," said Oliver Peoples, Ph.D., president and chief executive officer of Yield10 Bioscience. "During 2021, we will scale-up seed... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that management will participate at the Benzinga Global Small Cap Conference on May 14, 2021. President and Chief Executive Officer Oliver Peoples, Ph.D. will participate in a “Fireside Chat” session on the Disruptive Innovation track slated for 12:10 pm to 12:25 pm EDT on Friday, May 14, 2021. Dr. Peoples will also be available to... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its first quarter 2021 financial results and provide a corporate update on Tuesday, May 11, 2021. Management will host a conference call on Tuesday, May 11, 2021 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following management’s formal... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that it will be featured as a presenting company at the Benzinga Biotech Small Cap Conference to be held on March 24-25, 2021 in a virtual format. Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will provide an overview of the Company’s business during the presentation on Thursday, March 25 at 12:40 pm... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended December 31, 2020. "In 2020 we continued to execute our business plan, and successfully achieved key milestones required to utilize Camelina as a platform crop to produce fuel, food and PHA bioplastic," said Oliver Peoples, Ph.D., president and chief executive officer of Yield10... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announces that Chief Executive Officer Oliver Peoples, PhD. will present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference to be held March 17-19, 2021. Investors can view the Yield10 corporate presentation made by Dr. Peoples once they register for the conference here , and an archived replay of the presentation will be available... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2020 financial results and provide a corporate update on Tuesday, March 16, 2021. Management will host a conference call on Tuesday, March 16, 2021 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the Bank of America 2021 Virtual Global Agriculture & Materials Conference being held on March 3-4, 2021. On Thursday, March 4, 2021 at 7:00 am Eastern Time, Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10 Bioscience will present on the Bioplastics panel where he... Read More

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has received proceeds of approximately $3.8 million from the exercise of 472,099 warrants exercised between January 1, 2021 and February 16, 2021, and the Company has issued to investors 472,099 shares of common stock in exchange for the exercised warrants. The warrants were issued to investors pursuant to a public offering... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share. Gross proceeds before deducting underwriting discounts and commissions and other offering expenses are approximately $12.7 million. Existing investors, including shareholder Jack... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the pricing of its underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share. The gross proceeds from the public offering will be approximately $12.7 million, the maximum amount currently available to it under the company’s shelf registration statement, before deducting... Read More

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has commenced an underwritten public offering of shares of its common stock. The public offering is subject to market conditions, and there can be no assurance as to whether or when the public offering may be completed, or the actual size or terms of the public offering. Maxim Group LLC is acting as the sole book-running manager... Read More